HOME
SEARCH
RSS FEED
SUBSCRIBE
Search Results - burke
3
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Novel Small Molecule Inhibitors of Tyrosyl-DNA Phosphodiesterase 1 (TDP1) for Treatment of Solid Tumors
Summary: The NCI seeks proposals from parties interested in licensing and/or co-development for commercializing the use of TDP1 inhibitors as part of a potent and selective anti-cancer combination therapy. Description of Technology: Topoisomerase 1 (TOP1) is an essential enzyme that plays a critical role in DNA transcription and replication. TOP1...
Published: 4/23/2026
|
Updated: 8/2/2023
|
Inventor(s):
Xue Zhao
,
George Lountos
,
Evgeny Kiselev
,
David Waugh
,
Yves Pommier
,
Terrence
Burke
Keywords(s):
Burke
,
CANCER
,
solid tumor
,
Tdp1
,
TOP1
,
Topoisomerase 1
,
Tyrosyl-DNA Phosphodiesterase 1
,
Zhao
Category(s):
Application > Therapeutics
,
Collaboration Sought > Collaboration
,
Collaboration Sought > Licensing
,
TherapeuticArea > Oncology
Peptide Mimetic Ligands of Polo-like Kinase 1 Polo Box Domain
Abstract: Polo-like kinase 1 (Plk1) is a critical protein involved in regulation of mitosis, and aberrant expression of this kinase is found in various cancer types. Inhibition of Plk1 is currently being pursued in pre-clinical drug development for novel anti-cancer therapeutics. Plk1 contains an allosteric domain, known as the polo-box domain (PBD),...
Published: 4/22/2025
|
Updated: 8/2/2023
|
Inventor(s):
Terrence
Burke
,
Wen-Jian Qian
,
Kyung Lee
,
Jung-Eun Park
,
James Kelley
Keywords(s):
Burke
,
CANCER
,
mitosis
,
Peptide Inhibitor
,
polo-box domain (PBD)
,
Polo-like kinase 1 (Plk1)
,
therapeutic
Category(s):
Collaboration Sought > Collaboration
,
Collaboration Sought > Licensing
,
TherapeuticArea > Oncology
,
Application > Therapeutics
Peptide Mimetic Ligands of Polo-like Kinase 1 Polo Box Domain (“Plk1 PBD Portfolio”)
Abstract: Polo-like kinase 1 (Plk1) is a critical protein involved in regulation of mitosis, and aberrant expression of this kinase is found in various cancer types. Inhibition of Plk1 is currently being pursued in pre-clinical drug development for novel anti-cancer therapeutics. Plk1 contains an allosteric domain, known as the polo-box domain (PBD),...
Published: 4/22/2025
|
Updated: 8/2/2023
|
Inventor(s):
Terrence
Burke
,
Jung-Eun Park
,
Wen-Jian Qian
,
Fa Liu
,
Kyung Lee
Keywords(s):
Burke
,
CANCER
,
mitosis
,
Peptide Inhibitor
,
polo-box domain (PBD)
,
Polo-like kinase 1 (Plk1)
,
therapeutic
Category(s):
Collaboration Sought > Collaboration
,
Collaboration Sought > Licensing
,
TherapeuticArea > Oncology
,
Application > Therapeutics
Home
|
Search
|
RSS
|
Subscribe
© 2026. All Rights Reserved. Powered by
Inteum